State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Missouri

AstraZeneca and Novartis recently opposed covered entities’ efforts to dismiss lawsuits challenging Missouri's contract pharmacy access law.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Right-leaning Outlets Publish Contrasting Op-eds on 340B Program 

Competing op-eds published in right-leaning news sites highlighted the varying attitudes on the 340B program within conservative circles. 
The 340B program continues to draw attention in conservative media outlets, with one recently published opinion piece calling for preserving [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Sends New York Times More Documents Requested in 340B FOIA Lawsuit

U.S. Attorney Damian Williams updated a federal judge on the status of HRSA’s agreement to process the New York Times' requests for records.
The U.S. Health and Human Services Department has sent the New York Times hundreds of 340B-related documents and emails that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House Places 340B Transparency Act on Floor Calendar, But a Vote is Not Guaranteed

U.S. House lawmakers have placed the 340B Transparency Act on a list of bills that could come up for floor consideration.
More than a year after a key House panel passed legislation requiring 340B hospitals to report on a number of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Issues 1st State Report on 340B, Critics Say it ‘Misses Critical Context’ 

The Minnesota Department of Health on Monday unveiled the findings of its first legislatively required 340B Covered Entity Report.
Minnesota providers, namely the state’s largest 340B hospitals, generated hundreds of millions of dollars in collective net revenue from the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Arkansas SCOTUS Appeal and Updates in West Virginia, Mississippi

Key briefs were filed this week in litigation over state contract pharmacy access laws in Arkansas, West Virginia and Mississippi.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Proposition 34: Voters Narrowly Back Controversial California 340B ‘Revenge’ Ballot Measure

California voters narrowly endorsed Proposition 34, a controversial 340B-related ballot measure, in the Nov. 5 elections.
California voters have narrowly endorsed Proposition 34, a controversial Nov. 5 ballot measure that would require at least one major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Picks ‘Dr. Oz’ to Lead CMS, Key Agency that Influences 340B Program

President-elect Donald Trump has selected Mehmet Oz to lead CMS.
President-elect Donald Trump this week selected Mehmet Oz as his pick for Centers for Medicare & Medicaid Services (CMS) administrator, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More Dems Back 340B PATIENTS Act Which Would Restore 340B Discounts in Contract Pharmacy Setting

Two major community health center national advocacy groups have pushed aside their conflicting visions of 340B reform to jointly lobby Congress to reauthorize crucial health center funding ahead of a looming budget deadline.
Three additional House Democrats—including a high-profile New York congresswoman—have signed on as co-sponsors to legislation that would bar drugmaker restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Dismisses Lawsuit Challenging 340B ADR Rule

A Maryland federal judge granted PhRMA's request to dismiss its challenge to the government's 340B ADR process.
A Maryland federal judge recently granted an influential drug industry trade group’s request to dismiss its 2021 lawsuit challenging a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live